One such commonly used medication for dermatologic and rheumatologic inflammatory conditions is hydroxychloroquine (Plaquenil), a chloroquine derivative. It is used to treat many diseases including malaria, rheumatoid arthritis and systemic lupus erythematosus. Plaquenil rp Chloroquine trade name generic name Can hydroxychloroquine interfere with the immune system Plaquenil toxicity aao guidelines Of retinopathy, as a result of long term use of hydroxychloroquine. Evidence suggests the prevalence of hydroxychloroquine retinopathy has been underestimated and recommends a hospital based screening programme for patients to provide assurance that current treatment regimens are within safe parameters. HCQ is widely used for the treatment of rheumatic diseases, particularly lupus and RA. It is generally well tolerated, but retinopathy is a concern. Retinopathy is rare, but is sight threatening, generally irreversible and may progress even after cessation of therapy. Damage may be subclinical. Find an Ophthalmologist. Abstract Background The American Academy of Ophthalmology recommendations on screening for chloroquine CQ and hydroxychloroquine HCQ retinopathy are revised in light of new information about the prevalence of toxicity, risk factors, fundus distribution, and effectiveness of screening tools. It is imperative that patients and physicians are aware of and watch for this drug’s ocular side effects. Retinal toxicity from hydroxychloroquine is rare, but even if the medication is discontinued, vision loss may be irreversible and may continue to progress. Test for plaquenil retinopathy Revised Recommendations on Screening for Chloroquine and., Hydroxychloroquine-related retinal toxicity Rheumatology. Nursing responsibility of chloroquineChloroquine resistant malaria areasWhat must be evaluated while on hydroxychloroquine The results of the tests may be assessed after you. have left the clinic. When they have been assessed a report will be sent to you, your GP and/or the hospital doctor who prescribed hydroxychloroquine. No signs of retinopathy. If the tests do not show signs of retinopathy, you will be invited back for re-screening in one year. Eye screening for patients taking hydroxychloroquine Plaquenil®. Recommendations on Screening for Chloroquine and.. Eye screening for patients taking hydroxychloroquine Plaquenil. Today it is recommended that every single person on Plaquenil get a visual field 10-2 test, plus one of the three other highly sensitive screening tests the FAF fundus autofluorescence imaging, the SD-OCT spectral domain optical coherence, or the multifocal electroretinogram mfERG,” Thomas says. Clinical Information Discusses physiology, pathophysiology, and general clinical aspects, as they relate to a laboratory test. Hydroxychloroquine is an antimalarial drug used to treat or prevent malaria. It is highly effective against erythrocytic forms of Plasmodium, but not effective against exoerythrocytic forms of parasites. Hydroxychloroquine, sold under the brand name Plaquenil Sanofi-Aventis, is an antimalarial drug that has gained widespread use in treating various autoimmune diseases, including systemic lupus erythematosus and rheumatoid arthritis. 1 By some estimates, more than 150,000 patients are on long-term therapy with this medication in America alone. 2 Retinal toxicity associated with HCQ use is.